A new clinical trial design is being explored in precision medicine, involving discovery, development, and direction. The design appears to incorporate various approaches, including the use of artificial intelligence, multi-omics, and biomarker-driven strategies. These approaches are being applied to areas such as pharmaceutical innovation, rare disease research, and oncology drug development, with potential applications in precision drug discovery and clinical trials.